PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.35 +0.01 (+1.86%)
As of: Oct 22, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Revenue (2010 - 2012)

Updated

PharmaCyte Biotech (PMCB) reported Revenue of $12,160 for FY2013 (year ended Apr 30, 2013), down 81.7% from $66,558 in FY2012.

Analysis

PharmaCyte Biotech (PMCB) Revenue (2010 - 2012) Analysis & Trends

  • According to Business Quant data, Revenue came in at $66,558 in FY2012 (-47.2%) and $125,997 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 25.40 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 16.99 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 15.38 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 7.80 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 15.03 Bn
10 PharmaCyte Biotech 3.79 Mn -69.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2012 6,287.00
Jul 31, 2012 6,626.00
Apr 30, 2012 6,681.00
Jan 31, 2012 20,271.00
Oct 31, 2011 19,844.00
Jul 31, 2011 19,762.00
Apr 30, 2011 51,146.00
Jan 31, 2011 32,022.00
Oct 31, 2010 15,869.00
Jul 31, 2010 26,960.00
API Access

PharmaCyte Biotech Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=PMCB&period=max&api_key=YOUR_API_KEY